Lloyd Carney, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,400 shares at $321.84 ($1.4M) on 2023-01-30, disclosed to the SEC on 2023-01-31.
Open-market sale of $1.4M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $320.08 | 1,376 | $440K | 31.2% |
| 2 | $320.08 | 1,376 | $440K | 31.2% |
| 3 | $320.70 | 1,000 | $321K | 22.7% |
| 4 | $321.84 | 324 | $104K | 7.4% |
| 5 | $321.84 | 324 | $104K | 7.4% |
| Total | $320.48 avg | 4,400 |
| $1.4M |
| 100% |
| Filing → |
| V | SELL | 2024-04-26 | $501K | — | Filing → |
| GDYN | SELL | 2023-11-16 | $214K | — | Filing → |
| V | SELL | 2023-05-01 | $600K | — | Filing → |